Target intelligence / Profile preview

Alpha-neurotoxin (α-NTX) (α-NTX)

Target
α-NTX
Molecular classification
Other, Protein
01

Overview

Alpha-neurotoxins are a major class of potent proteins found in the venom of elapid snakes, such as cobras and kraits, and are members of the three-finger toxin (3FTx) superfamily [UniProt: Family: Three-finger toxin family]. These toxins are characterized by a conserved structural motif of three beta-stranded loops extending from a hydrophobic core [Tsetlin, V. I. (1999). Eur. J. Biochem.]. Their primary biological function is the high-affinity, competitive antagonism of nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction [Barber, C. M., et al. (2013). Toxicon]. By blocking acetylcholine binding, they prevent muscle depolarization, leading to progressive flaccid paralysis and potentially fatal respiratory failure [WHO Snakebite Envenoming]. In clinical practice, these toxins are the primary targets for neutralization by antivenoms, which consist of purified antibodies that bind the toxin and prevent its interaction with host receptors [StatPearls: Snake Toxicity]. While antivenoms are the standard of care, challenges include the rapid onset of action of these toxins and the risk of anaphylactic reactions to the treatment [PubMed: Antivenom Safety].

Other names
Three-finger toxin3FTxPostsynaptic neurotoxinSnake neurotoxinAlpha-bungarotoxinCobratoxin
02

Mechanism of action

Antivenoms neutralize the toxin by binding to its active sites or surrounding epitopes, sterically hindering the toxin's ability to bind to the nicotinic acetylcholine receptor and facilitating its systemic clearance.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Antivenom-induced anaphylaxisSerum sicknessRapid progression to respiratory arrestIrreversible binding of long-chain neurotoxins
06

Interacting drugs

Antivenom (Polyvalent/Monovalent)

2 more in the full profile.

07

Biomarkers

Venom antigen levels (ELISA)Ptosis (clinical sign)Respiratory capacity (3-count breath test)Decremental response on repetitive nerve stimulation (RNS)

Beyond the preview

Go deeper on Alpha-neurotoxin (α-NTX) (α-NTX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-neurotoxin (α-NTX) (α-NTX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call